Chiarenza A - Search Results

1

Mitogenic effect of nerve growth factor (NGF) in LNCaP prostate adenocarcinoma cells: role of the high- and low-affinity NGF receptors.

Sortino MA, Condorelli F, Vancheri C, Chiarenza A, Bernardini R, Consoli U, Canonico PL. Sortino MA, et al. Among authors: chiarenza a. Mol Endocrinol. 2000 Jan;14(1):124-36. doi: 10.1210/mend.14.1.0402. Mol Endocrinol. 2000. PMID: 10628752

2

Tamoxifen inhibits nerve growth factor-induced proliferation of the human breast cancerous cell line MCF-7.

Chiarenza A, Lazarovici P, Lempereur L, Cantarella G, Bianchi A, Bernardini R. Chiarenza A, et al. Cancer Res. 2001 Apr 1;61(7):3002-8. Cancer Res. 2001. PMID: 11306479

3

Apomorphine, dopamine and phenylethylamine reduce the proportion of phosphorylated insulin receptor substrate 1.

Chiarenza A, Scarselli M, Novi F, Lempereur L, Bernardini R, Corsini GU, Maggio R. Chiarenza A, et al. Eur J Pharmacol. 2001 Dec 14;433(1):47-54. doi: 10.1016/s0014-2999(01)01491-1. Eur J Pharmacol. 2001. PMID: 11755133

4

Divergent effects of corticotropin releasing hormone on endothelial cell nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptors.

Cantarella G, Lempereur L, Lombardo G, Chiarenza A, Pafumi C, Zappalà G, Bernardini R. Cantarella G, et al. Among authors: chiarenza a. Br J Pharmacol. 2001 Oct;134(4):837-44. doi: 10.1038/sj.bjp.0704322. Br J Pharmacol. 2001. PMID: 11606324 Free PMC article.

5

Rat hypothalamic corticotropin-releasing hormone secretion is stimulated by interleukin-1 in an eicosanoid-dependent manner.

Bernardini R, Mauceri G, Chiarenza A. Bernardini R, et al. Among authors: chiarenza a. Pharmacol Res. 1990 Sep-Oct;22 Suppl 3:61. doi: 10.1016/s1043-6618(09)80030-3. Pharmacol Res. 1990. PMID: 2097647 No abstract available.

6

Responsiveness of irradiated rat anterior pituitary cells to hypothalamic releasing hormones is restored by treatment with growth hormone.

Chiarenza A, Lempereur L, Palmucci T, Cantarella G, Amico-Roxas M, Goffin V, Murabito P, Magro G, Bernardini R. Chiarenza A, et al. Neuroendocrinology. 2000 Dec;72(6):392-9. doi: 10.1159/000054608. Neuroendocrinology. 2000. PMID: 11146422

7

The immune-adrenal feedback: basic aspects.

Bernardini R, Chiarenza A, Iurato MP, Scapagnini U. Bernardini R, et al. Among authors: chiarenza a. Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:665A-666A. doi: 10.1097/00002826-199201001-00344. Clin Neuropharmacol. 1992. PMID: 1498994 No abstract available.

8

The phospholipid drug glyceryl-phosphoryl-O-serine modulates pituitary adrenocorticotropin and hypothalamic corticotropin releasing hormone in vitro secretion in the aging rat.

Chiarenza A, Lempereur L, Cantarella G, Barbera N, Maugeri M, Scapagnini U, Bernardini R. Chiarenza A, et al. Pharmacol Toxicol. 1995 Jan;76(1):63-7. doi: 10.1111/j.1600-0773.1995.tb00104.x. Pharmacol Toxicol. 1995. PMID: 7753760

9

Modulating effects of the synthetic thymic dipeptide pidotimod on the immune system in the aging rat.

Chiarenza A, Iurato MP, Barbera N, Lempereur L, Cantarella G, Scapagnini U, Bernardini R. Chiarenza A, et al. Pharmacol Toxicol. 1994 Apr-May;74(4-5):262-6. doi: 10.1111/j.1600-0773.1994.tb01109.x. Pharmacol Toxicol. 1994. PMID: 8090697

10

Adenylate-cyclase-dependent pituitary adrenocorticotropin secretion is defective in the inflammatory-disease-susceptible Lewis rat.

Bernardini R, Iurato MP, Chiarenza A, Lempereur L, Calogero AE, Sternberg EM. Bernardini R, et al. Among authors: chiarenza a. Neuroendocrinology. 1996 May;63(5):468-74. doi: 10.1159/000127073. Neuroendocrinology. 1996. PMID: 8738585

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters